_1689489558 20230716063918000 Rovedar Daryoushbabazadeh@gmail.com Rovedar Journal of Veterinary Physiology and Pathology J. Vet. Physiol. Pathol. 2821-0328 06 05 2023 2 2 Ali Jahanmahin Hassan Borji Toxocariasis, caused by Toxocara parasites, is a prevalent parasitic disease affecting millions of people worldwide. Conventional anthelmintic drugs for toxocariasis face challenges such as limited efficacy and potential adverse effects, necessitating exploring alternative therapeutic strategies. Nanotechnology has emerged as a promising approach for the treatment of toxocariasis. This prospective review provides an overview of the potential of nanotechnology in toxocariasis treatment and highlights critical advancements in the field. The current review aimed to provide an overview of toxocariasis and the current challenges in its treatment, such as limited efficacy and potential adverse effects. It emphasized the need for novel therapeutic approaches to overcome these limitations. The subsequent section focused on nanoparticle-based drug delivery systems, discussing the nanoparticles used in toxocariasis treatment, their advantages, and strategies for enhancing drug delivery efficiency. Nanotechnology in targeted therapy is a great strategy to treat toxocariasis. It explored targeting Toxocara parasites using nanoparticles, surface modifications for enhanced targeting, and controlled release and sustained drug delivery techniques. Nanodiagnostics and imaging techniques in diagnosing and monitoring provide promising futures for controlling toxocariasis. It explored the use of nanosensors for the sensitive detection of Toxocara parasites and various imaging modalities for parasite visualization. These advancements enabled timely intervention and personalized treatment strategies. Furthermore, the application of nanotechnology in vaccine development is fruitful for preventing toxocariasis. It highlights the use of nano vaccines for enhanced immune responses, controlled antigen delivery, and targeted immune cell activation. In conclusion, nanotechnology holds immense potential in the treatment of toxocariasis. Its unique features, such as targeted drug delivery, enhanced diagnostics, and improved vaccine efficacy, offer promising avenues for more effective and personalized approaches. Addressing evaluation, regulatory approval, cost-effectiveness, and scalability challenges is crucial for successful translation into clinical practice. The advancements in nanotechnology can potentially revolutionize toxocariasis treatment and improve patient outcomes. 06 25 2023 12 19 https://creativecommons.org/licenses/by/4.0 10.58803/jvpp.v2i2.24 https://jvpp.rovedar.com/index.php/JVPP/article/view/24 https://jvpp.rovedar.com/index.php/JVPP/article/download/24/30 https://jvpp.rovedar.com/index.php/JVPP/article/download/24/30 10.58803/fahn.v1i2.10 Düzlü Ö, Inci A, Yıldırım A, Doğanay M, Özbel Y, and Aksoy S. Vector-borne zoonotic diseases in Turkey: Rising threats on public 10.4274/tpd.galenos.2020.6985 10.1007/s11686-023-00680-3 Sadr S, Charbgoo A, Borji H, and Hajjafari A. Interactions between innate immunity system and Echinococcus granulosus: Permission for vaccine development. Series Med Sci. 2022; 3(1): 1-18. Available at: https://seriesscience.com/wp-content/uploads/2023/01/ Interactions-between-Innate-Immunity.pdf 10.54203/scil.2023.wvj7 10.1016/j.onehlt.2021.100301 10.4103/ijcm.IJCM_398_19 10.1017/S0031182021001591 10.2478/s11686-019-00166-1 10.1016/bs.apar.2020.01.016 10.1016/bs.apar.2020.02.001 10.1016/j.ejmech.2023.115268 10.3347/kjp.2021.59.3.189 10.3390/biom10030426 10.2174/2210681206666160726164457 10.58803/fahn.v1i1.9 10.1002/wnan.1852 10.1016/j.jddst.2021.102487 10.1016/j.cis.2022.102734 Abbasi AM, Eftekhari Hasan Abad MR, and Saeed M. The role of mesenchymal stem cell therapy in echinococcus granulosus treatment: A prospective review. J Lab Anim Res, 2023; 2(2): 6-10. Available at: https://jlar.rovedar.com/index.php/JLAR/article/view/15 10.1016/j.microc.2018.05.024 Mohammadi Aloucheh R, Alaee Mollabashi Y, Asadi A, Baris O, and Gholamzadeh S. The role of nanobiosensors in identifying pathogens and environmental hazards. Anthropog Pollut J. 2018; 2(2): 16-25. Available at: https://ap.ardabil.iau.ir/article_543109_456771351b f66a327aeaf9964dfc6b79.pdf 10.3389/fimmu.2020.576748 Molento MB, and Arenal A. The breakthrough of nanotechnology to veterinary parasitology research. LALIOTIS, GP current research in agriculture and veterinary science. London: Publisher International; 2020: p. 71-77. 10.1039/D1CS00918D 10.1016/j.glohj.2023.02.008 10.3390/pharmaceutics14112463 10.1016/j.actatropica.2007.08.006 10.1016/j.vetpar.2004.12.017 10.1007/s40089-016-0198-3 Muraleedharan K, and Chhabra M. Nanotechnology applications and potential in parasitology: An overview. Vet Immunol Immunopathol. 2018; 1(1): 25-48. Available at: https://isvib.org/Download/ VIB%201(1)%20Final.pdf#page=33 10.1016/j.ejpb.2010.03.017 10.2174/2211738508666200524233724 10.1016/j.jconrel.2016.01.008 10.1016/j.jddst.2020.101961 Chopra H, Dey PS, Das D, Bhattacharya T, Shah M, Mubin S, et al. Curcumin nanoparticles as promising therapeutic agents for 10.3390/molecules26164998 10.2217/nnm-2017-0102 10.1016/j.arcontrol.2019.08.001 Badar A, Pachera S, Ansari A, and Lohiya N. Nano based drug delivery systems: Present and future prospects. Nanomed Nanotechnol J. 2019; 2(1): 121. 10.1080/10717544.2017.1284945 10.3390/nano12081333 10.1016/j.microc.2016.10.027 10.1007/s11356-021-12996-6 Ashour DS. Ivermectin: From theory to clinical application. 10.1016/j.ijantimicag.2019.05.003 10.1016/j.nantod.2014.04.008 10.1038/nrd2591 10.1017/S0031182019001665 10.1128/CMR.00329-20 10.1021/cr200359p 10.1039/C2LC40864C 10.1080/17425247.2022.2047020 10.1186/s40249-018-0437-0 10.4103/1687-7942.192997 10.1002/VIW.20200025 Shahrokhi A, Moradpour N, Siahsarvie R, and Borji H. An investigation of potentially zoonotic helminth parasites of allactaga elater in Sarakhs, Iran. J Lab Anim Rese. 2022; 1(1): 8-13. Available at: https://jlar.rovedar.com/index.php/JLAR/article/view/7 Haji Mohammadi K, Heidarpour M, Moosavi Z, and Borji H. Histopathological and biochemical evaluation of albendazole in the treatment of infected mice with hydatid cyst. J Lab Anim Rese. 2022; 1(1): 1-7. Available at: https://jlar.rovedar.com/index.php/JLAR/ article/view/6 10.1016/j.cmi.2018.04.028 10.1016/j.isci.2020.101432 10.1080/21505594.2017.1371897 10.1053/j.semnuclmed.2017.10.004 10.1155/2019/2179718 10.1016/B978-0-323-85725-3.00005-2 10.1002/adhm.201801546 10.1016/j.addr.2010.09.002 10.1007/978-3-030-98820-3_11 10.1089/vim.2017.0049 10.3390/vaccines9090988 10.1016/j.procbio.2020.09.028 10.3390/polym10010031 10.1615/CritRevTherDrugCarrierSyst.2020033273 10.1038/s41578-021-00372-2 Alsharedeh RH, Rezigue M, Bashatwah RM, Amawi H, Aljabali AA, Obeid MA, et al. Nanomaterials as a potential target for 10.2174/1567201820666230223085403 Qaemifar N, Borji H, and Adhami G (2023). The antiparasitic properties of allium sativum: Can it be used as a complementary treatment for echinococcosis?. J Lab Anim Res, 2(1): 1-5. Available at: https://jlar.rovedar.com/index.php/JLAR/article/view/14 10.3390/nano11112991